Skip to main content

ADVERTISEMENT

treatment patterns

From the Field
05/19/2022
Robert Reid, MD
Yiqiong Xie, PhD, MPH
Junxin Shi, PhD
Katrine L Wallace, PhD
Dr Wallace and colleagues analyzed second-line poly(ADP-ribose) polymerase inhibitor (PARPi) maintenance therapy in a real-world setting to understand how it is being utilized and the resultant impact on patients’ disease course.
Dr Wallace and colleagues analyzed second-line poly(ADP-ribose) polymerase inhibitor (PARPi) maintenance therapy in a real-world setting to understand how it is being utilized and the resultant impact on patients’ disease course.
Dr Wallace and colleagues...
05/19/2022
Journal of Clinical Pathways
Research Reports
09/22/2021
Thomas A Abrams, MD
Gary Meyer, PhD
Lisa M Hess, PhD
Sui Zhang, MS, MPP
Astra M Liepa, PharmD
Yajun Zhu, MS
Jeffrey A Meyerhardt, MD, MPH
Deborah Schrag, MD, MPH
Peter C Enzinger, MD
Charles S Fuchs
Thomas A. Abrams, MD, and colleagues examine patterns of systemic therapy administration in metastatic gastric cancer and the predictors associated with specific treatment choices.
Thomas A. Abrams, MD, and colleagues examine patterns of systemic therapy administration in metastatic gastric cancer and the predictors associated with specific treatment choices.
Thomas A. Abrams, MD, and...
09/22/2021
Journal of Clinical Pathways